心臟幫浦設備市場報告：2031 年趨勢、預測與競爭分析

預計未來全球心臟幫浦設備市場將在醫院和心臟中心市場迎來機會。預計到 2031 年，全球心臟幫浦設備市場規模將達到 80 億美元，2025 年至 2031 年的複合年成長率為 20.3%。該市場的主要促進因素是肥胖症盛行率的上升、該設備在心臟移植手術中的使用增加以及心血管疾病的發生率上升。

• Lucintel 表示，根據類型，預測期內植入式裝置將繼續佔據較大的市場佔有率，這是因為不適合進行心臟移植的心臟衰竭患者的需求不斷成長。
• 在最終用途類別中，醫院預計將繼續成為主要部分，因為大量的外科手術、心血管疾病的增加以及熟練專家的可用性正在推動醫院對心臟泵設備的需求。
• 從地區來看，預計北美將在預測期內繼續成為最大的地區，因為該地區人口心臟病患病率高、醫療保健基礎設施強大且有主要企業存在。

心臟幫浦設備市場的策略性成長機會

與心臟泵設備市場相關的各種應用中存在著許多策略性成長機會。了解這些機會對於希望積極參與心血管護理和技術變革的相關人員來說非常重要。

• 擴展到新興市場：由於心臟病發病率上升導致醫療保健投資增加，擴展到新興市場具有良好的成長前景。為有需求的地區開發具有成本效益且易於獲得的產品可以開拓新的市場。
• 整合數位健康技術：將數位健康技術整合到輔助人工心臟中有可能改善患者的監測和管理。遠端監控不僅可以改善設備功能，還可以透過即時資料分析來改善臨床結果，從而創造新的市場。
• 以患者為中心的設計開發：專注於以患者為中心的設計有助於推動心血管幫浦的採用。提高患者舒適度、易用性和與生活方式無縫融合的創新將成為需求的主要驅動力，並可以提高患者對治療的依從性。
• 生物相容性發展：生物相容性心臟幫浦的發展將創造新的成長機會。這項技術減少了併發症的可能性並延長了設備的使用壽命，使其對患者和醫療保健提供者都更具吸引力並擴大了市場。
• 夥伴關係與協作：製造商、研究機構和醫療服務提供者之間的策略夥伴關係正在加速創新和市場進入。此次合作不僅促進了技術進步，也擴大了市場。

這些機會顯示心臟幫浦設備市場有著光明的成長前景。相關人員可以利用新興趨勢和策略性舉措來產生創新，改善患者健康狀況並可能創造新的市場。

心臟幫浦設備市場促進因素與挑戰

各種促進因素​​和挑戰影響心臟幫浦設備市場的發展和成長。了解這些因素對於開拓這個市場並解決心臟護理中的關鍵問題至關重要。

推動心臟幫浦設備市場發展的因素如下：

1. 技術進步：由於技術進步，例如具有高度生物相容性的下一代 LVAD（左心室輔助裝置），市場正在不斷擴大。這些改進使得這些設備的性能更加出色，從而導致需求隨著用戶採用率的提高而增加。

2. 心血管疾病盛行率上升：全球心血管疾病盛行率不斷上升，導致全球心臟幫浦的市場佔有率不斷增加。隨著越來越多的患者尋求更好的護理，需要先進的心臟泵技術。

3. 監管部門的核准和支持：監管部門的核准以及對新型心臟泵技術的支持正在加速其市場發展。結合簡化的核准流程，這加快了創新設備進入診所和醫院的速度，擴大了治療選擇。

4. 研發投資：增加研發支出有助於創新心臟幫浦技術的發展。這筆資金籌措鼓勵開發更有效率的設備並有助於推動市場發展。

5. 提高意識和教育：病人和醫療保健專業人員對心臟病學和先進方法的了解不斷增加，導致對心血管幫浦的需求增加。患者和醫療保健提供者的理解不斷提高，推動了這些技術的採用。

心臟幫浦設備市場面臨的挑戰包括：

1. 先進設備高成本：先進心臟幫浦設備的高成本對市場成長構成了挑戰。昂貴的技術可能會限制其可近性和採用率，尤其是在醫療預算較低的地區。

2. 監管和報銷障礙：製造商經常難以應對該行業面臨的監管和報銷障礙。複雜的核准流程和報銷問題可能會減緩市場進入進程並對設備接受率產生不利影響。

3. 設備併發症和管理：感染疾病和設備故障等問題可能導致與心臟幫浦相關的醫療併發症，使患者照護和安全問題變得複雜。解決這些問題對於提高設備可靠性和臨床結果將變得越來越重要。

多種促進因素​​和挑戰正在影響心臟幫浦設備市場的發展和成長。解決這些因素將有助於相關人員駕馭市場，同時有助於改善心血管護理。

目錄

第1章執行摘要

第2章全球心臟幫浦設備市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 2019年至2031年市場趨勢及預測分析

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球心臟幫浦設備市場趨勢（2019-2024）及預測（2025-2031）
• 全球心臟幫浦設備市場類型
  • 植入式心臟幫浦裝置
  • 體外心臟幫浦裝置
• 全球心臟幫浦設備市場（依產品類型）
  • 心室輔助裝置（VAD）
  • 全人工心臟（TAH）
  • 主動脈內球囊幫浦（IABP）
  • 體外膜氧合（ECMO）
• 全球心臟幫浦設備市場（依最終用途分類）
  • 醫院
  • 心臟中心
  • 其他

第4章2019年至2031年區域市場趨勢與預測分析

• 區域心臟幫浦設備市場
• 北美心臟幫浦設備市場
• 歐洲心臟幫浦設備市場
• 亞太心臟幫浦設備市場
• 世界其他地區心臟幫浦設備市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球心臟幫浦設備市場成長機會（按類型）
  • 全球心臟幫浦設備市場成長機會（依產品類型）
  • 全球心臟幫浦設備市場最終用途的成長機會
  • 區域心臟幫浦設備市場的成長機會
• 全球心臟幫浦設備市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球心臟幫浦設備市場產能擴張
  • 全球心臟幫浦設備市場的合併、收購與合資企業
  • 認證和許可

第7章主要企業簡介

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

The future of the global heart pump device market looks promising with opportunities in the hospital and cardiac center markets. The global heart pump device market is expected to reach an estimated $8 billion by 2031 with a CAGR of 20.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of obesity, the rising use of this device in heart transplant procedures, and the escalating incidence of cardiovascular disorders.

• Lucintel forecasts that, Within the type category, implanted will remain the larger segment over the forecast period due to its rising need among patients suffering from heart failure who are not eligible for a heart transplant.
• Within the end-use category, hospitals will remain the larger segment due to the increased need for heart pump devices in this setting owing to the number of surgeries being done, growing incidences of cardiovascular disorders, and availability of qualified specialists.
• In terms of regions, North America will remain the largest region over the forecast period due to high heart disease rates among the population, the existence of robust healthcare infrastructure, and the presence of key players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Heart Pump Device Market

The heart pump device market is evolving with emerging trends that mirror advancements in technology, patient care, and changes within the market itself. Understanding these trends can therefore provide insight into how this industry has changed over time and where it may be headed next in terms of innovative heart pumps.

• Miniaturization of Devices: There is a trend toward miniaturization and efficiency improvement with smaller devices. This can be attributed to advances in materials science and engineering that make procedures less invasive, thus enhancing patients' comfort. Small implants also allow better integration into patients' lives and enable them to move around freely without any hassle.
• Integration with Digital Health: This trend has seen heart pumps integrated into digital health technologies. Remote monitoring along with data analytics has greatly improved device management and patient care. This opens up real-time assessment of both device performance and patient health, thereby leading to prompt actions or targeted curative procedures through such insights.
• Improved Biocompatibility: Advances in material science have led to improved biocompatibility of ventricular assist devices. New materials and coatings have reduced the risks of complications and resulted in better long-term performance of devices. Ensuring biocompatibility is crucial for patient safety and device longevity.
• Focus on Patient-Centric Designs: There has been an increasing focus on designing heart pumps with patients' comfort and lifestyle in mind. These include ergonomic designs, reduced device profiles, and user-friendly interfaces. This trend aims to improve how patients experience healthcare services and their compliance with therapies.
• Expansion into Emerging Markets: The heart pump market is entering emerging markets due to increased healthcare investments and the growing incidence of cardiovascular diseases. In these regions, firms are developing cost-effective solutions that enhance accessibility and affordability concerning heart pump technologies.

These emerging trends are redefining the heart pump device market by improving device functionality, enhancing patient outcomes, and expanding market reach. The shift toward miniaturization, digital integration, or patient-centric design characterizes a broader transformation toward more effective and accessible cardiovascular care.

Recent Developments in the Heart Pump Device Market

In recent times there have been significant advancements within the heart pump device market due to technological advancements made as well as regulatory approvals granted thereby expanding the industry's geographical footprint. Such developments are defining future treatment approaches for cardiovascular complications globally thus leading to improved patient results.

• Next-Generation LVADs: Significant progress has been achieved by introducing next-generation Left Ventricular Assist Devices (LVADs) which are more durable than ever before leading to fewer complications. Through this, these devices offer better clinical outcomes for patients while extending their lifespan addressing key problems concerning HF therapy at hand.
• FDA Approvals for Innovative Designs: Recently FDA-approved new designs for artificial hearts have widened treatment options for many patients who need them across America. Among other things, some innovations include wireless monitoring systems such as those with advanced features like the one that can detect some chemicals contributing to better patient management and care. Emergence of Local Manufacturers:
• In developing markets, local manufacturing has resulted in cheap heart pumps. Such a trend makes advanced cardiovascular technologies more accessible and affordable, particularly for high HF disease burden regions.
• Technological Advances in Biocompatibility: With advancements in materials & coatings, the biocompatibility of artificial hearts is enhanced. New methods are reducing risks of complications and ensuring longer functioning as they are crucial for long-term patient care.
• Increased Investment in R&D: Increased R&D investment stimulates innovation in heart pump technology. Firms are striving to develop more efficient, durable, and patient-friendly units thereby pushing the limits of current artificial heart capabilities.

Through technology enhancement, expanded access or improved patient outcomes, these developments have significantly impacted on heart pump device market. The ongoing advances indicate a commitment towards addressing HF challenge as well as advancing cardiovascular care globally for every individual suffering from it.

Strategic Growth Opportunities for Heart Pump Device Market

The numerous strategic growth opportunities exist within various applications related to heart pump device market. Understanding these opportunities becomes important for stakeholders who want to participate actively in changing landscape of cardiovascular treatment and technology.

• Expansion into Emerging Markets: Going to emerging markets provides excellent growth prospects due to increased investments in healthcare along with higher incidence of cardiac diseases. This can lead to new markets expansion by developing cost effective and accessible products for those areas where demand exists.
• Integration of Digital Health Technologies: There is an opportunity to integrate digital health technologies with ventricular assist devices that could improve patients' monitoring and management. Remote monitoring enables device function as well as better clinical results through real-time data analytics hence creating new marketplaces.
• Patient-Centric Designs Development: A focus on patient-centric designs can encourage the uptake of cardiovascular pumps. Innovations that promote patients' comfort, ease of use, and seamless integration with their way of life can be major drivers of demand and enhance patient adherence to treatment.
• Biocompatibility Developments: Developing heart pumps that have better biocompatibility creates new opportunities for growth. This technology lowers the chance of complications occurring and increases the lifespan of the devices, making them more attractive to patients and providers alike hence creating wider markets.
• Partnerships and Collaborations: Strategic partnerships between manufacturers, research institutions, and healthcare providers can accelerate innovation as well as market entry. These collaborations result in advancement in technologies as well as expansive market coverage.

These opportunities reveal a promising future for growth within the heart pump device market. Stakeholders may utilize emerging trends along with strategic initiatives to create innovations and improve health outcomes for their patients thereby creating new markets.

Heart Pump Device Market Driver and Challenges

Different drivers and challenges influence the development and growth of the heart pump device market. Comprehending these elements is vital to traversing this marketplace while addressing critical problems in cardiac care delivery.

The factors responsible for driving the heart pump device market include:

1. Technological Advancements: Market expansion is caused by technological advancements such as next generation LVADs (Left Ventricular Assist Devices) which have better biocompatibility. Such improvements make these devices perform better thus contributing to increased adoption rates by users leading to high demands.

2. Rising Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases worldwide has grown resulting in increased heart pump market share globally. Increased numbers of patients are seeking better treatments for their lives thus needing advanced heart pumping technologies.

3. Regulatory Approvals and Support: Regulatory approvals together with support for novel heart pump technologies are driving overall market development at an increasing pace. Favorable legislation coupled with streamlined approval processes help quicken introduction of innovative gadgets into clinics or hospitals expanding treatment options.

4. Investment in Research and Development: Rising expenditure on R&D is contributing towards the growth of innovative heart pump technologies. This funding type facilitates the creation of devices that are more efficient and effective thus boosting market development.

5. Growing Awareness and Education: Improved patient as well as health professional knowledge about heart disease and advanced approach has led to increased demand for cardiovascular pumps. Greater understanding among patients and healthcare providers supports the adoption of such technologies.

Challenges in the heart pump device market are:

1. High Costs of Advanced Devices: The high costs associated with advanced heart pump devices pose a challenge for market growth. Expensive technologies can limit accessibility and adoption, particularly in regions with lower healthcare budgets.

2. Regulatory and Reimbursement Hurdles: Manufacturers often struggle to navigate their way through regulatory as well as reimbursement hurdles facing this industry. Complex approval processes coupled with reimbursement issues may slow down the process of entering the market thereby negatively influencing device acceptance rates.

3. Device Complications and Management: Problems like infections or device malfunctioning among others result in medical complications associated with cardiac pumps which then put pressure on patient care and safety issues. Fixing these problems will become increasingly important for enhancing clinical outcomes along with device reliability.

Several drivers or challenges impact the heart pump device market leading to its development or growth. These factors should be addressed by stakeholders so that they successfully navigate across the market while contributing towards improved cardiovascular care.

List of Heart Pump Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart pump device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart pump device companies profiled in this report include-

• Abbott
• ABIOMED
• CorWave
• LivaNova
• Berlin Heart
• SynCardia Systems
• Jarvik Heart
• BiVACOR
• Leviticus Cardio
• Evaheart

Heart Pump Device by Segment

The study includes a forecast for the global heart pump device market by type, product type, end use, and region.

Heart Pump Device Market by Type [Analysis by Value from 2019 to 2031]:

• Implanted Heart Pump Devices
• Extracorporeal Heart Pump Devices

Heart Pump Device Market by Product Type [Analysis by Value from 2019 to 2031]:

• Ventricular Assist Devices (VADs)
• Total Artificial Hearts (TAHs)
• Intra-Aortic Balloon Pumps (IABPs)
• Extracorporeal Membrane Oxygenation (ECMO)

Heart Pump Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Cardiac Centers
• Others

Heart Pump Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Heart Pump Device Market

The market for heart pump devices is moving rapidly due to technological breakthroughs and the rise in demand for effective cardiovascular treatment. Significant strides have been made toward innovation and market growth in the U.S., China, Germany, India, and Japan. These improvements are part of a continued effort to combat heart failure and enhance patient outcomes with advanced cardiac devices.

• United States: Recent developments in the U.S. heart pump device market include the FDA's approval of a new generation of Left Ventricular Assist Devices (LVADs) that are more durable and have fewer complications. Innovations from companies like Abbott and Medtronic are leading the way with better integration and remote monitoring capabilities. These improvements aim to enhance patients' quality of life and broaden the use of heart pumps in treating advanced stages of heart failure.
• China: In China, investment in cardiovascular healthcare, coupled with technological advances, has contributed to growth within the heart pump device market. Chinese firms like MicroPort and LifeTech are developing affordable heart pumps tailored to their local markets. Such innovations make it easier for people to access affordable heart pumps, thus helping to control escalating disease burdens.
• Germany: On a European scale, Germany plays a leading role in heart pump technology advancement, with recent innovations focusing on miniature versions that can be implanted beneath a patient's skin. Companies like Berlin Heart and Fresenius are developing new models that guarantee improved patient comfort and longer durability. This development stems from Germany's strong healthcare infrastructure and increased R&D efforts, establishing it as an innovation leader for heart pumps.
• India: The heart pump device market in India is evolving based on affordability and accessibility concerns. Domestic manufacturers are creating cost-effective alternatives for coronary artery disease, which is prevalent among a larger population segment characterized by inadequate access to these devices given its purchasing power parity compared to other countries. The government's approach, along with relationships formed with foreign organizations, has aided in the introduction of modern technologies aimed at advancing care and improving treatment outcomes for patients with cardiac failure.
• Japan: Japan is making strides in heart pump technology with a focus on next-generation devices that offer enhanced biocompatibility and functionality. Compactness, durability, and heart pumps for the elderly population are among the critical concerns pursued by companies like Terumo and Japan Lifeline. These initiatives are improving patient outcomes while widening the application of cardiac support devices for heart failure management.

Features of the Global Heart Pump Device Market

Market Size Estimates: Heart pump device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Heart pump device market size by type, product type, end use, and region in terms of value ($B).

Regional Analysis: Heart pump device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, product types, end uses, and regions for the heart pump device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart pump device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the heart pump device market by type (implanted heart pump devices and extracorporeal heart pump devices), product type (ventricular assist devices (VADs), total artificial hearts (TAHs), intra-aortic balloon pumps (IABPs), and extracorporeal membrane oxygenation (ECMO)), end use (hospitals, cardiac centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Pump Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Heart Pump Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Heart Pump Device Market by Type
  • 3.3.1: Implanted Heart Pump Devices
  • 3.3.2: Extracorporeal Heart Pump Devices
• 3.4: Global Heart Pump Device Market by Product Type
  • 3.4.1: Ventricular Assist Devices (VADs)
  • 3.4.2: Total Artificial Hearts (TAHs)
  • 3.4.3: Intra-Aortic Balloon Pumps (IABPs)
  • 3.4.4: Extracorporeal Membrane Oxygenation (ECMO)
• 3.5: Global Heart Pump Device Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Cardiac Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Heart Pump Device Market by Region
• 4.2: North American Heart Pump Device Market
  • 4.2.1: North American Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.2.2: North American Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.3: European Heart Pump Device Market
  • 4.3.1: European Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.3.2: European Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.4: APAC Heart Pump Device Market
  • 4.4.1: APAC Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.4.2: APAC Market by End Use: Hospitals, Cardiac Centers, and Others
• 4.5: ROW Heart Pump Device Market
  • 4.5.1: ROW Market by Type: Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices
  • 4.5.2: ROW Market by End Use: Hospitals, Cardiac Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Heart Pump Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Heart Pump Device Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Heart Pump Device Market by End Use
  • 6.1.4: Growth Opportunities for the Global Heart Pump Device Market by Region
• 6.2: Emerging Trends in the Global Heart Pump Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Heart Pump Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Pump Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: ABIOMED
• 7.3: CorWave
• 7.4: LivaNova
• 7.5: Berlin Heart
• 7.6: SynCardia Systems
• 7.7: Jarvik Heart
• 7.8: BiVACOR
• 7.9: Leviticus Cardio
• 7.10: Evaheart